Thomas K. Equels

2014

In 2014, Thomas K. Equels earned a total compensation of $1.7M as CEO & President at Hemispherx Biopharma, a 85% increase compared to previous year.

Compensation breakdown

Bonus$774,990
Option Awards$69,199
Salary$719,273
Other$104,987
Total$1,668,449

Equels received $775K in bonus, accounting for 46% of the total pay in 2014.

Equels also received $69.2K in option awards, $719.3K in salary and $105K in other compensation.

Rankings

In 2014, Thomas K. Equels' compensation ranked 5,307th out of 13,032 executives tracked by ExecPay. In other words, Equels earned more than 59.3% of executives.

ClassificationRankingPercentile
All
5,307
out of 13,032
59th
Division
Manufacturing
1,894
out of 4,965
62nd
Major group
Chemicals And Allied Products
634
out of 1,690
63rd
Industry group
Drugs
485
out of 1,369
65th
Industry
Biological Products, Except Diagnostic Substances
84
out of 241
65th
Source: SEC filing on July 18, 2017.

Equels' colleagues

We found three more compensation records of executives who worked with Thomas K. Equels at Hemispherx Biopharma in 2014.

2014

William Carter

Hemispherx Biopharma

Chief Executive Officer

2014

David Strayer

Hemispherx Biopharma

Chief Scientific Officer

2014

Adam Pascale

Hemispherx Biopharma

Chief Financial Officer

News

You may also like